Page 18 - P4403.14_V102_YOUROTC March 2025

18 ALLERGY

Discover the e‡ective purple allergy range.

NEW

HIVES SYMPTON
RELIEF

Eœective multi-symptom Prescription strength itch relief from

allergy relief. hives – without a prescription.

Allevia 120 mg tablets Product Information Allevia Hives 180 mg tablets Abbreviated Product Information
Presentation: Allevia (fexofenadine hydrochloride) 120mg film-coated tablets, containing equivalent to 112mg of fexofenadine. Presentation: Allevia Hives 180 mg tablets containing fexofenadine hydrochloride 180 mg.
Indications: Relief of symptoms associated with allergic rhinitis in adults and children 12 years and older. Indications: Relief of symptoms associated with chronic idiopathic urticaria in adults and children 12 years and older.
MA holder: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK. Contact email: uk-medicalinformation@sanofi.com. MA holder: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK, contact email:
Legal category: GSL. Further information about this product including adverse reactions, precautions, contraindications and method uk-medicalinformation@ sanofi.com.
MAT-XU-2500017 (V1.0) January 2025
of use can be found at: Allevia 120mg tablets - Summary of Product Characteristics (SmPC) - (emc) (medicines.org.uk) Legal category: P. Information about this product including adverse reactions, precautions,
contraindications and method of use can be found at: https://www.medicines.org.uk/emc
Date of preparation: January 2023
Date of preparation: January 2025
Document number: MAT-XU-2500105 (v1.0) Date of Preparation: January 2025
Corresponding SmPC: Dated 10 January 2024

acts within 1 hour
non drowsy 24 hour relief
in most people

Pricing Area